Pacira BioSciences Balance Sheet
NASDAQ: PCRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pacira BioSciences financial position
At the end of fiscal 2025, Pacira BioSciences reported total assets of $1.26 billion, down 18.6% from a year earlier against total liabilities of $571.8 million. Shareholders' equity stood at $693.1 million, or 54.8% of assets. The company held $158.5 million in cash and equivalents against $372.2 million of debt, a net debt position of $213.6 million.
The current ratio (current assets divided by current liabilities) was 4.54, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.54.
Summary generated from market data by MetaCap's automated system. Methodology
Pacira BioSciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 158.54M | 276.77M | 153.30M | 104.14M | 585.58M | 99.96M | 78.23M | 132.53M | 54.13M | 35.94M |
| Short-Term Investments | 79.88M | 207.84M | 125.28M | 184.51M | 70.83M | 421.70M | 213.72M | 250.93M | 257.22M | 136.65M |
| Receivables | 124.07M | 113.30M | 105.56M | 98.40M | 96.32M | 53.05M | 47.53M | 38.00M | 31.66M | 29.94M |
| Inventory | 152.86M | 125.28M | 104.35M | 96.06M | 98.55M | 64.65M | 58.30M | 48.57M | 41.41M | 31.28M |
| Total Current Assets | 547.97M | 745.13M | 509.99M | 498.33M | 866.05M | 651.62M | 408.56M | 477.97M | 391.11M | 243.09M |
| Property, Plant & Equipment | 140.69M | 167.17M | 173.93M | 183.51M | 188.40M | 136.69M | 104.68M | 108.67M | 107.05M | 101.02M |
| Goodwill | 20.21M | 0 | 163.24M | 163.24M | 145.20M | 99.55M | 99.55M | 62.04M | 55.20M | 46.74M |
| Intangible Assets | 368.10M | 425.97M | 483.26M | 540.55M | 623.97M | 96.52M | 104.39M | 0 | — | 0 |
| Long-Term Investments | — | 0 | 2.41M | 37.21M | 0 | 95.46M | 64.80M | 25.87M | 60.05M | 0 |
| Total Assets | 1.26B | 1.55B | 1.57B | 1.68B | 2.08B | 1.27B | 831.07M | 689.35M | 628.37M | 391.47M |
| Accounts Payable | 15.15M | 19.13M | 15.70M | 15.22M | 10.54M | 10.43M | 12.80M | 14.37M | 14.66M | 7.51M |
| Short-Term Debt | 0 | 201.78M | — | — | — | — | — | — | — | 118.53M |
| Total Current Liabilities | 120.59M | 309.92M | 97.38M | 147.77M | 521.12M | 253.33M | 107.67M | 60.66M | 56.22M | 44.84M |
| Long-Term Debt | 372.19M | 383.55M | 522.44M | 689.47M | — | — | — | — | — | 108.74M |
| Total Liabilities | 571.81M | 775.17M | 704.26M | 906.19M | 1.34B | 654.83M | 476.12M | 368.13M | 348.89M | 172.49M |
| Shareholders' Equity | 693.11M | 778.35M | 870.13M | 775.01M | 730.41M | 619.69M | 354.94M | 321.23M | 279.48M | 218.98M |
| Retained Earnings | -199.32M | -206.36M | -106.80M | -148.75M | -211.90M | -253.88M | -399.40M | -388.23M | -389.14M | -346.24M |
| Total Debt | 372.19M | 585.32M | 522.44M | 689.47M | — | — | — | — | — | 227.27M |
| Net Cash (Debt) | -133.76M | -100.71M | -243.86M | -400.82M | 656.41M | 521.66M | 291.95M | 383.45M | 311.35M | -54.67M |
| Shares Outstanding | 41.12M | 46.24M | 46.48M | 45.93M | 44.73M | 43.64M | 41.91M | 41.22M | 40.67M | 37.48M |
This table shows 10 annual periods of Pacira BioSciences's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PCRX's reporting calendar. What is a balance sheet?